Back

AEBSF Hydrochloride BioChemica

Assay (titr., calc. on dried substance): min. 98 %
Code
A1421
CAS
30827-99-7
Molecular Formula
C8H10FNO2S · HCl
Molar mass
239.69 g/mol

Recommended prices only. For prices and orders please contact your local distributor.
Box prices only valid with purchase of full box.

code packaging size price per unit box price per unit
Code & packaging Price per piece
A1421,0100
code
A1421,0100
packaging size
100 mg
Product active until stock lasts.
A1421,0500
code
A1421,0500
packaging size
500 mg
price per unit
single $275,10
box price per unit
A1421,0001
code
A1421,0001
packaging size
1 g
price per unit
single $344,70
box price per unit
Solubility:
50 g/L (H2O)
Physical Description:
Solid
Product Code:
A1421
Product Name:
AEBSF Hydrochloride BioChemica
Specifications:
Assay (titr., calc. on dried substance): min. 98 %
Assay (HPLC): min. 98 %
Loss on drying: max. 1.0 %
Hazard pictograms
  • GHS05 Hazard
WGK:
1
Storage:
2 - 8°C
Signal Word:
Danger
GHS Symbols:
GHS05
H Phrases:
H314
P Phrases:
P280
P303+P361+P353
P305+P351+P338
P310
P321
P405
P501
CS:
29214900
Download TDS file for complete specifications

Literature

(1) Walsmann, P. et al. (1972) Acta biol. med. germ. 28, 577-585. Inactivation of Trypsin and Thrombin through 4-Amidinobenzene sulfonyl fluoride and 4-(2-Aminoethyl)-benzene sulfonyl fluoride. (2) Markwardt, F. et al. (1973) Thrombosis Res. 2, 343-348. Synthetic low molecular weight inhibitors of serum kallikrein. (3) Murphy,. B.J. et al. (1993) J. Biol. Chem. 268, 27355-27362. Identification of the sites of selective phosphorylation and dephosphorylation of the rat brain Na+ channel α subunit by cAMP-dependent protein kinase and phosphoprotein phosphatases. (4) Nathan, D.F. & Lindquist. S. (1995) Mol. Cell. Biol. 15, 3917-3925. Mutational analysis of HSP90 function: Interactions with a steroid receptor and a protein kinase. (5) Taylor, J.A. et al. (1995) Mol. Cell. Biol. 15, 4149-4157. Activation of the high-affinity immunoglobulin E receptor FceRI in RBL-2H3 cells is inhibited by syk SH2 domains. (6) Taylor, J.A. et al. (1995) Immunology 86, 629-635. Serine protease inhibitors block the priming of monocytes for enhanced superoxide release.